These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1767784)

  • 1. [Clinical studies of terodiline hydrochloride and clenbuterol hydrochloride for urinary frequency and incontinence].
    Katsumi T; Murayama K; Tajika E; Nakamura T; Kawaguchi K
    Hinyokika Kiyo; 1991 Nov; 37(11):1575-80. PubMed ID: 1767784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical effect of terodiline hydrochloride on pollakisuria and urinary incontinence].
    Sugiyama T; Kiwamoto H; Uchida A; Nagai N; Park YC; Kurita T; Ikegami M; Nakanishi A; Kawamura M; Umekawa T
    Hinyokika Kiyo; 1990 Nov; 36(11):1371-7. PubMed ID: 2288317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experience in the use of propiverine hydrochloride (P-4) for patients suffering from urinary frequency and/or incontinence].
    Yokoyama O; Miyazaki K; Ishida T; Fujita Y; Hisazumi H
    Hinyokika Kiyo; 1990 Apr; 36(4):517-23. PubMed ID: 2378310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical evaluation of terodiline hydrochloride in patients with urinary frequency or incontinence].
    Yasuno H; Ogawa T; Arakawa S; Matsumoto O; Kamidono S; Kataoka N; Matsushita M; Inaba Y; Umezu K; Yamashita M
    Hinyokika Kiyo; 1991 Apr; 37(4):431-9. PubMed ID: 1892003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical evaluation of long-term administration of terodiline hydrochloride for the treatment of patients with pollakisuria and incontinence].
    Tsujimoto Y; Fujisue H; Shima H; Ikoma F; Sakurai T; Sato Y; Tokizane M; Akiyama K; Kato S; Nakachi K
    Hinyokika Kiyo; 1988 Apr; 34(4):724-32. PubMed ID: 3400552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical effects of clenbuterol-HCL in urge incontinence and stress incontinence].
    Yamanishi T; Yasuda K; Nagashima K; Naoto ; Murayama ; Tojo M; Shimazaki J
    Hinyokika Kiyo; 1990 Feb; 36(2):207-11. PubMed ID: 2343815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical effects of oxybutynin hydrochloride (Pollakis)--especially in the treatment of pollakisuria, urgency and urinary incontinence].
    Yamauchi K; Ohashi K; Osanai H; Inagaki N; Yamaguchi S; Hashimoto H; Yachiku S
    Hinyokika Kiyo; 1990 Dec; 36(12):1485-90. PubMed ID: 2075888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical effect of terodiline hydrochloride on nervous pollakisuria or irritative bladder].
    Yoneyama T; Ogawa A; Fukui J; Wajiki M; Tomita Y; Igawa Y; Yanagisawa A; Uchiyama S; Watanabe K; Aida Y
    Hinyokika Kiyo; 1987 Feb; 33(2):319-26. PubMed ID: 3591595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical effectiveness of KL 007 (oxybutynin hydrochloride) in urinary disorders].
    Takimoto Y; Kiyotaki S; Kawazoe K; Fuse T; Kitamura K; Yamamoto T; Satoh Y; Okada K; Kishimoto T
    Hinyokika Kiyo; 1985 Dec; 31(12):2284-301. PubMed ID: 3832931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical effect of oxybutynin hydrochloride (1 mg/tablet)].
    Yokoyama E; Fujino A; Kubo S; Mashimo S; Koshiba K
    Hinyokika Kiyo; 1990 Jul; 36(7):869-76. PubMed ID: 2239587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of long-term administration with terodiline hydrochloride for the treatment of patients with neurogenic bladder].
    Ishido T; Miyazaki K
    Hinyokika Kiyo; 1988 Apr; 34(4):754-8. PubMed ID: 3400554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of long-term safety and clinical benefit of terodiline in women with urgency/urge incontinence. A multicentre study.
    Fischer-Rasmussen W
    Scand J Urol Nephrol Suppl; 1984; 87():35-47. PubMed ID: 6443541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical study of terodiline hydrochloride for the treatment of urinary frequency and urinary incontinence, and its cardiovascular adverse effects].
    Yoshihara H; Yasumoto R; Kishimoto T; Maekawa M; Horii A; Nishijima T; Sugimoto T; Kashiwara N; Tsujita M; Senjyu M
    Hinyokika Kiyo; 1992 Aug; 38(8):967-72. PubMed ID: 1414748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of long-term administration of oxybutynin hydrochloride (KL007) for the treatment of neurogenic bladder and unstable bladder].
    Sonoda T; Sakurai T; Yamada K; Mizutani S; Tsujimoto Y; Ogawa T
    Hinyokika Kiyo; 1989 Jan; 35(1):167-78. PubMed ID: 2658513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recommendations for the urodynamic examination in the investigation of non-neurological female urinary incontinence].
    Hermieu JF;
    Prog Urol; 2007 Nov; 17(6 Suppl 2):1264-84. PubMed ID: 18214138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical effects of terodiline hydrochloride on urinary frequency and sense of residual urine--a double blind clinical trial using flavoxate hydrochloride as a control].
    Ogawa A; Shimazaki J; Mitsuya H; Miyazaki S; Kurita T
    Hinyokika Kiyo; 1988 Apr; 34(4):739-53. PubMed ID: 3041785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical study of terodiline hydrochloride on nervous pollakisuria].
    Park YC; Uchida A; Ohnishi N; Kiwamoto H; Esa A; Sugiyama T; Kaneko S; Kurita T
    Hinyokika Kiyo; 1989 Mar; 35(3):537-40. PubMed ID: 2735258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical effect of propiverine hydrochloride on urinary incontinence].
    Watanabe H; Uchida M; Kojima M
    Hinyokika Kiyo; 1998 Mar; 44(3):199-206. PubMed ID: 9589886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra.
    Smith CP; Nishiguchi J; O'Leary M; Yoshimura N; Chancellor MB
    Urology; 2005 Jan; 65(1):37-41. PubMed ID: 15667859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term administration study of propiverine hydrochloride (BUP-4 tablets) in pollakiuria and urinary incontinence].
    Noguchi K; Masuda M; Noguchi S; Kubota Y; Hosaka M; Senga Y; Sano K; Miyai K; Kanno H; Kitami K; Fujinami K; Miura T; Kondo I; Kawasaki C; Moriyama M; Hara Y; Ida T; Fukuoka H; Nakagawa J; Kitajima N; Fukuda M; Satomi Y; Takahashi T; Yamaguchi T; Shiozaki H
    Hinyokika Kiyo; 1998 Sep; 44(9):687-93. PubMed ID: 9805679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.